Technical

The M&A Fund initiated by Jiuzhitang achieved new progress in its investment efforts in the stem cells field – Stemedica Cell Technologies, Inc. of which the Fund has holding interests announced positive data from its clinical study on cerebral stroke.


On January 12, 2019, the M&A Fund initiated by Jiuzhitang achieved new progress in its investment efforts in the stem cells field – Stemedica Cell Technologies, Inc. a compnay which received investment from Yonghe Qihang Fund initiated by Jiuzhitang announced positive data from its clinical study on cerebral stroke.